Ubs Asset Management Americas Inc Harmony Biosciences Holdings, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 95,389 shares of HRMY stock, worth $3.39 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,389
Previous 62,331
53.04%
Holding current value
$3.39 Million
Previous $2.14 Million
47.62%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$235 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$208 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$167 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$56.2 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$45.8 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.1B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...